01 4Gowling WLG (Canada) LLP
02 8Lundbeck Canada Inc.
01 42462110
02 42655212
03 42705163
01 12VORTIOXETINE HYDROBROMIDE
01 12TABLET
01 42022-10-02
02 42027-06-15
03 42028-11-12
Patent Expiration Date : 2028-11-12
Date Granted : 2013-02-12
Brand Name : TRINTELLIX
Patent Number : 2705163
Filing Date : 2008-11-12
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-11-12
Date Granted : 2013-02-12
Patent Expiration Date : 2022-10-02
Date Granted : 2014-05-13
Brand Name : TRINTELLIX
Patent Number : 2462110
Filing Date : 2002-10-02
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-10-02
Date Granted : 2014-05-13
Patent Expiration Date : 2027-06-15
Date Granted : 2012-07-31
Brand Name : TRINTELLIX
Patent Number : 2655212
Filing Date : 2007-06-15
Strength per Unit : 5 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-06-15
Date Granted : 2012-07-31
Patent Expiration Date : 2022-10-02
Date Granted : 2014-05-13
Brand Name : TRINTELLIX
Patent Number : 2462110
Filing Date : 2002-10-02
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-10-02
Date Granted : 2014-05-13
Patent Expiration Date : 2027-06-15
Date Granted : 2012-07-31
Brand Name : TRINTELLIX
Patent Number : 2655212
Filing Date : 2007-06-15
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-06-15
Date Granted : 2012-07-31
Patent Expiration Date : 2028-11-12
Date Granted : 2013-02-12
Brand Name : TRINTELLIX
Patent Number : 2705163
Filing Date : 2008-11-12
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-11-12
Date Granted : 2013-02-12
Patent Expiration Date : 2022-10-02
Date Granted : 2014-05-13
Brand Name : TRINTELLIX
Patent Number : 2462110
Filing Date : 2002-10-02
Strength per Unit : 15 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-10-02
Date Granted : 2014-05-13
Patent Expiration Date : 2027-06-15
Date Granted : 2012-07-31
Brand Name : TRINTELLIX
Patent Number : 2655212
Filing Date : 2007-06-15
Strength per Unit : 15 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2027-06-15
Date Granted : 2012-07-31
Patent Expiration Date : 2028-11-12
Date Granted : 2013-02-12
Brand Name : TRINTELLIX
Patent Number : 2705163
Filing Date : 2008-11-12
Strength per Unit : 15 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-11-12
Date Granted : 2013-02-12
Patent Expiration Date : 2022-10-02
Date Granted : 2014-05-13
Brand Name : TRINTELLIX
Patent Number : 2462110
Filing Date : 2002-10-02
Strength per Unit : 20 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2022-10-02
Date Granted : 2014-05-13
